abagovomab 24
abciximab 27
abituzumab 22
abrilumab 19
actoxumab 16
adalimumab 19
aducanumab 12
afasevikumab 15
alacizumab_pegol 12
alemtuzumab 23
alirocumab 21
amatuximab 39
andecaliximab 21
anifrolumab 20
anrukinzumab 19
aprutumab 18
aprutumab_ixadotin 18
arcitumomab 24
ascrinvacumab 7
atezolizumab 16
atinumab 16
avelumab 14
basiliximab 26
bavituximab 36
begelomab 25
benralizumab 25
bevacizumab_beta 20
bezlotoxumab 16
bimagrumab 13
bleselumab 12
blinatumomab 30
blosozumab 29
bococizumab 15
brazikumab 15
brentuximab_vedotin 30
briakinumab 17
brodalumab 9
brolucizumab 25
brontictuzumab 24
burosumab 17
cabiralizumab 25
camrelizumab 11
canakinumab 20
cantuzumab_ravtansin 44
carlumab 13
carotuximab 29
cergutuzumab_amunaleukin2 23
cergutuzumab_amunaleukin 23
certolizumab_pegol 25
cetiximab 45
citatuzumab_bogatox 27
cixutumumab 26
clivatuzumab_tetraxetan 21
codrituzumab 29
conatumumab 11
concizumab 29
crenezumab 19
crizanlizumab 25
crotedumab 21
dacetuzumab 22
daclizumab 10
dalotuzumab 34
dapirolizumab_pegol 23
daratumumab 14
dectrekumab 10
demcizumab 21
denosumab 10
depatuxizumab 22
depatuxizumab_mafodotin 22
dezamizumab 18
dinutuximab 34
diridavumab 24
domagrozumab 15
drozitumab 14
duligotuzumab 21
durvalumab 8
dusigitumab 14
efalizumab 32
efungumab 29
eldelumab 14
elezanumab 19
elgemtumab 11
elotuzumab 17
emactuzumab 17
emapalumab 25
emibetuzumab 14
enavatuzumab 24
enfortumab_vedotin 14
enoblituzumab 20
enokizumab 23
enoticumab 18
ensituximab 31
eptinezumab 19
erenumab 22
etaracizumab 15
etrolizumab 22
evinacumab 22
evolocumab 13
farletuzumab 8
fasinumab 21
fezakinumab 19
fibatuzumab 10
ficlatuzumab 20
firivumab 34
flanvotumab 18
fletikumab 18
foralumab 13
foravirumab 14
fremanezumab 28
fresolimumab 17
fulranumab 20
futuximab 25
galcanezumab 18
ganitumab 26
gantenerumab 11
gemetuzumab 27
gemtuzumab2 25
gemtuzumab 19
gevokizumab 21
girentuximab 27
glembatumumab 17
glembatumumab_vedotin 17
guselkumab 23
ibalizumab 24
ibritumomab 31
icrucumab 10
idarucizumab 34
ifabotuzumab 10
imalumab 18
imgatuzumab 19
inclacumab 20
indatuximab_ravtansin 29
indusatumab 11
inebilizumab 22
intetumumab 12
iodine_girentuximab 29
ipilimumab 3
iratumumab 6
isatuximab 34
itolizumab 27
ixekizumab 31
labetuzumab_govitecan 19
lambrolizumab 23
lampalizumab 23
lanadelumab 18
landogrozumab 18
laprituximab 24
lebrikizumab 34
lendalizumab 23
lenzilumab 15
lifastuzumab_vedotin 25
ligelizumab 21
lilotomab 34
lirilumab 22
lodelcizumab 16
lokivetmab 23
lorvotuzumab_mertansin 26
lucatumumab 28
lumretuzumab 17
lupartumab 16
lutikizumab 20
margetuximab 31
milatuzumab 39
mirvetuximab 29
mirvetuximab_soravtansin 29
modotuximab 36
mogamulizumab 31
monalizumab 16
motavizumab 32
moxetumomab_pasudotox 32
namilumab 16
naratuximab 28
naratuximab_emtansin 28
narnatumab 15
navicixizumab2 27
navicixizumab 24
navivumab 32
necitumumab 12
nemolizumab 24
nesvacumab 17
nivolumab 12
obiltoxaximab 21
obinutuzumab 36
ocaratuzumab 26
ofatumumab 19
olaratumab 19
olokizumab 24
omalizumab 19
onartuzumab 21
ontuxizumab 22
opicinumab 14
orticumab 16
otelixizumab 37
oxelumab 12
ozanezumab 31
pamrevlumab 11
panobacumab 30
parsatuzumab 24
pasotuxizumab 23
pateclizumab 16
patritumab 18
pembrolizumab 23
perakizumab 23
pidilizumab 17
pinatuzumab_vedotin 19
plozalizumab 33
pogalizumab 22
polatuzumab_vedotin 22
ponezumab 37
prezalumab 15
pritoxaximab 28
quilizumab 21
racotumomab 26
radretumab 15
ralpancizumab 20
ramucirumab 14
ranevetmab 27
ranibizumab 23
refanezumab 22
remtolumab 19
rilotumumab 13
rinucumab 17
risankizumab 32
rituximab 17
rivabazumab 20
robatumumab 20
roledumab 28
romosozumab 18
rontalizumab 19
rosmantuzumab 21
rozanolixizumab 20
sacituzumab 28
sacituzumab_govitecan 28
samalizumab 23
sapelizumab 23
sarilumab 18
secukinumab 13
seribantumab 17
setoxaximab 39
sifalimumab 8
siltuximab 25
simtuzumab 25
sirukumab 12
solanezumab 27
solitomab 23
stamulumab 16
suptavumab 22
suvizumab 18
tabalumab 10
tadocizumab 18
tamtuvetmab 31
tanezumab 22
tarextumab 11
tavolixizumab 18
telisotuzumab 26
teplizumab 17
tesidolumab 22
tezepelumab 23
tigatuzumab 17
tildrakizumab 19
timolumab 13
tisotumab 13
tosatoxumab 39
tositumomab 31
tralokinumab 22
trastuzumab 23
tregalizumab 24
trevogrumab 12
ublituximab 28
urelumab 18
ustekinumab 28
utomilumab 26
vadastuximab 23
vadastuximab_talirin 23
vandortuzumab_vedotin 14
vantictumab 20
vanucizumab2 20
vanucizumab 26
varlilumab 14
vatelizumab 21
vedolizumab 23
veltuzumab 13
vesencumab 12
vorsetuzumab 20
vorsetuzumab_mafodotin 20
vunakizumab 29
xentuzumab 20
zatuximab 36
